Double-Blind Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis Patients

Huang Hui; Dai Hua Ping; Kang Jian; Chen Bao Yuan; Sun Tie Ying; Xu Zuo Jun

首页> 外文期刊>Medicine. >Double-Blind Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis Patients

【24h】

Double-Blind Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis Patients

机译：吡非尼酮在中国特发性肺纤维化患者中的双盲随机试验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Idiopathic pulmonary fibrosis (IPF) lacks effective treatment. Pirfenidone has been used to treat IPF patients. N-acetylcysteine (NAC) exerts antioxidant and antifibrotic effects on IPF cases.

机译：特发性肺纤维化（IPF）缺乏有效的治疗方法。吡非尼酮已用于治疗IPF患者。 N-乙酰半胱氨酸（NAC）对IPF病例具有抗氧化和抗纤维化作用。

著录项

来源
《Medicine. 》 |2015年第42期| 共9页
作者
Huang Hui; Dai Hua Ping; Kang Jian; Chen Bao Yuan; Sun Tie Ying; Xu Zuo Jun;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生 ;
关键词

相似文献

外文文献
中文文献
专利

1. Double-Blind Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis Patients [J] . Huang Hui, Dai Hua Ping, Kang Jian, Medicine. . 2015 ,第42期

机译：吡非尼酮在中国特发性肺纤维化患者中的双盲随机试验
2. Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial [J] . Behr Juergen, Bendstrup Elisabeth, Crestani Bruno, The lancet. Respiratory medicine. . 2016 ,第6期

机译：乙酰半胱氨酸和吡非尼酮联合疗法在特发性肺纤维化中的安全性和耐受性：一项随机，双盲，安慰剂对照的2期临床试验
3. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. [J] . Noble PW, Albera C, Bradford WZ, The Lancet . 2011 ,第9779期

机译：吡非尼酮在特发性肺纤维化（CAPACITY）患者中：两项随机试验。
4. Acoustic evaluation of pirfenidone on patients with combined pulmonary fibrosis emphysema syndrome [C] . Sonia Charleston-Villalobos, Norma Castañeda-Villa, Ramón Gonzàlez-Camarena, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：吡非尼酮对合并肺纤维化性肺气肿综合征的声学评价
5. Correlation of Vascular Leak Measured Using Gadofosveset-Enhanced Lung Magnetic Resonance Imaging with Radiographic and Physiologic Measures of Fibrosis in Patients with Idiopathic Pulmonary Fibrosis. [D] . Liang, Lloyd. 2018

机译：特发性肺纤维化患者使用Gadofosveset增强肺磁共振成像测得的血管渗漏与纤维化的放射学和生理学指标的相关性。
6. Double-Blind Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis Patients [O] . Hui Huang, Hua Ping Dai, Jian Kang, -1

机译：吡非尼酮在中国特发性肺纤维化患者中的双盲随机试验
7. Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial [O] . Jürgen Behr, Steven D Nathan, Wim A Wuyts, 2021

机译：Sildenafil的疗效和安全性添加到患有先进特发性肺纤维化患者的皮里芬酮和肺动脉高压风险：双盲，随机，安慰剂控制，第2B期试验

Double-Blind Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis Patients

摘要

著录项

相似文献

相关主题

期刊订阅